HC Wainwright & Co. Reiterates Buy on PolyPid, Maintains $14 Price Target
Portfolio Pulse from Benzinga Newsdesk
HC Wainwright & Co. has reiterated its Buy rating on PolyPid (NASDAQ:PYPD) and maintained a price target of $14.
August 15, 2024 | 10:50 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
HC Wainwright & Co. has reiterated its Buy rating on PolyPid and maintained a price target of $14.
The reiteration of a Buy rating and a maintained price target of $14 by HC Wainwright & Co. is a positive signal for investors, likely boosting short-term confidence and stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100